Table 2.
Details of preclinical and clinical studies reporting the effects of various flavonoids on adult neurogenesis.
| Model | Flavonoid | Outcome Measurement (Technique) | Pathway | Outcome | References | 
|---|---|---|---|---|---|
| Mouse C17.2 cells Male C57BL/6 mice (6 weeks old) | Baicalein In vitro (1 or 10 mM) In vivo (10 mg/kg/day) | ROS measurements, cell counting, immunohistochemistry, immunostaining, and BDNF assay | Decreased oxidative stress and increased BDNF-pCREB signaling | Attenuate impaired hippocampal neurogenesis Protected neural progenitor cells against irradiation-induced necrotic cell death | [151] | 
| Male Sprague-Dawley rats (5 weeks old) | Hesperidin (100 mg/kg) | Immunofluorescence, cell counting, Western blot, and biochemical analysis | Increased levels of BDNF, Nrf2, and antioxidant enzymes | Alleviated methotrexate-induced neurogenesis decline | [162, 163] | 
| Male Fischer 344 rats (20 months old) | Flavonoid-rich extract from blueberry and green tea (135 mg/kg/day) | Immunohistochemistry, stereology, real time PCR, and ELISA | Anti-inflammatory effects, increased Nrf2, and activated Wnt/ β-catenin pathway | Increased neurogenesis and the number of proliferating cells in SVZ Activated pro-neurogenic gene expression in the hippocampal SGZ and SVZ | [168-169] | 
| Male Fischer 344 rats (19 months old) | Flavonoid-rich blueberry extract (20 g/kg) | Immunohistochemistry and cell quantification | Activated IGF-1, IGF-1R, and ERK1/2 | Increased hippocampal neurogenesis and hippocampal plasticity | [171] | 
| C. elegans nematodes | Multiple flavonoids including isoquercitrin | Drug screening and network-based analysis, genetic tests, drug assays, real time PCR, and Western blot | Increased daf-16/FoxO sir2-1/SIRT1 and ucp-4/UCP | Promoted neuronal function in C. elegans nematodes with neuronal stable expression of human polyglutamine-expanded (128Q) exon-1 huntingtin | [172] | 
| Male Wistar rats | Naringin (40 and 80 mg/kg) | Biochemical analyses | Attenuated mitochondrial oxidative damage and acetyl cholinesterase activity | Neuroprotective effects against aluminium chloride-induced cognitive dysfunction | [175] | 
| Male ICR mice (6 weeks old) | Spinosyn (5 mg/kg) | Immunohistochemistry, immunofluorescence, Western blot, and cell counting | Increased pERK, pCREB and mature BDNF | Increased proliferation and survival of neuronal cells, and the number of immature neurons | [177] | 
| Male ICR mice (6 weeks old) | Oroxylin A (1.25, 2.5, 5, or 10 mg/kg) | Immunohistochemistry and immunofluorescence | - | Increased progenitor cell proliferation and new-born cell survival | [178] | 
| Ts65Dn mice (12 weeks old) | Luteolin (10 mg/kg) | Immunohistochemistry, Nissl staining, and Western blot | Activated ERK1/2 and increased BDNF levels | Enhanced neuron proliferation in the hippocampal DG | [179] | 
| Rat PC12 cells | Luteolin (5, 10, and 20 μM) | Cell culture, neurite outgrowth analysis, real time PCR, Western blot, and analysis of Nrf2 | ERK-dependent induction of Nrf2-driven HO-1 expression | Induced neurite outgrowth and neuronal differentiation | [180] | 
| Rat PC12 cells | Luteolin (20 mM) | Quantification of neurite outgrowth, real time PCR, Western blot, and enzyme immunoassay | Activated cAMP/PKA and ERK-dependent CREB signaling pathways | Enhanced neurite outgrowth | [182] | 
| Male C57BL/6 mice (9 weeks old) | Heptamethoxyflavone (25 or 50 mg/kg/day) | Western blot and immunofluorescence microscopy | Activated ERK1/2 and increased pCREB and BDNF | Enhanced neurogenesis after brain ischemia | [183] | 
| Male C57BL/6J mice (6-7 weeks old) | Baicalin (40, 80 or 160 mg/kg) | Immunohistochemistry and Western blot | Normalized GR function through SGK1- and FKBP5-mediated GR phosphorylation | Restored corticosterone; induced suppression of hippocampal neurogenesis | [184] | 
| Male ICR mice (7-8 weeks old) | Baicalin (50 and 100 mg/kg) | Nissl staining, immunofluorescence, Western blot, and real time PCR | Activated Wnt/β-catenin pathway | Restored stress-induced suppression of hippocampal neurogenesis and improved nerve cells’ survival | [185] | 
| Male ICR mice (6 weeks old) | Quercetin (50 mg/kg/day) | Immunohistochemistry and Western blot | Increased Akt phosphorylation | Enhanced NSC neurogenesis in the hippocampal DG | [186] | 
| Female Sprague-Dawley rats and C57B6/BL mice Hippocampal NPC from day 18 rat fetuses | Ginkgo biloba extract containing quercetin (3-15 μM) | Cell proliferation assay, immunostaining, and immunoblotting | Increased pCREB and BDNF | Enhanced hippocampal cell proliferation Restored amyloid-β oligomer-induced synaptic loss | [187] | 
| Male ICR mice NPCs from brain of embryonic day 12-14 and SH-SY5Y cells | Quercetin In vivo (15 or 30 mg/kg) In vitro (0-90 μM, NPCs; 0-480 μM, SH-SY5Y) | Immunofluorescence and immunohistochemistry | Activated FoxG1/ CREB/BDNF pathway | Increased neurogenesis markers in the hippocampal DG | [188] | 
| Pathogen-free female mice (4 weeks old) | Purple cauliflower (174.32 mg/g anthocyanin) | Western blot, immunohistochemistry, and Golgi staining | Activated ERK/CREB/ BDNF pathway | Enhanced hippocampal neurogenesis and dendrite development | [189] | 
| NSCs from SVZs of 3-week-old and 23-month-old C57BL/6 mice C57BL/6 mice (12 months old) | Ribes meyeri anthocyanins (100 mg/kg) Naringenin (20 mg/kg) | Cell counting, cell cycle analyses, real time PCR, telomere length measurement, ROS assay, neurosphere and differentiation assays, immunofluorescence, RNA-sequencing, and ELISA | Decreased NSC senescence markers, and downregulated TNF-α | Accelerated NSC proliferation, and reversed age-dependent neuronal loss | [190] | 
| Male ICR mice | Cyanidin (25 or 50 mg/kg) | Immunofluorescence and Western blot | Activated PI3K/AKT/ FoxG1/FGF-2 pathway | Enhanced neurogenesis | [191] | 
| Male C57BL/6J mice (3 months old) | (-)-Epicatechin (1 mg/kg) (+)-Epicatechin (0.1 mg/kg) | Immunohistochemistry, immunofluorescence, nitrate/nitrite measurements, and Western blot | Enhanced capillary formation and nitric oxide triggering | Increased neuronal proliferation and neurofilament | [194] | 
| Healthy subjects (50-69 years old) | High-flavanol cocoa (900 mg/day flavanols, 138 mg/day (-)-epicatechin) | fMRI and cognitive testing | - | Enhanced DG function | [195] | 
| Male C57BL/6J mice (10 weeks old) | Cinnamtannin A2 (100 mg/kg) | Immunohistochemistry | - | Enhanced neurogenesis in the hippocampal DG | [196] | 
| Female Balb/c mice (6 weeks old) | Puerarin (80 mg/kg/day) | Histology analysis, immunostaining, and real time PCR | Increased GR, DCX, and BDNF expression | Ameliorated d-galactose-induced loss of neurogenesis | [197] | 
| Female C57BL/6J mice (12 months old) | Daidzein (25 mg/kg) | Tissue sectioning, molecular marker analyses, immunohistochemistry, optical dissector analysis, morphometric analysis, fluorescence intensity analysis | - | Increased markers of hippocampal neurogenesis, such as: increased numerical densities of late transient amplifying progenitors, neural progenitors, immature granule cells, and arborization of dendrites | [198] | 
Abbreviations: ROS, reactive oxygen species; BDNF, brain-derived neurotrophic factor; CREB, cAMP-response element binding; pCREB, phosphorylated CREB; Nrf2, nuclear factor erythroid 2-related factor 2; PCR, polymerase chain reaction; ELISA, enzyme-linked immunosorbent assay; SVZ, subventricular zone; SGZ, subgranular zone; IGF-1, insulin-like growth factor 1; IGF-1R, IGF-1 receptor; ERK, extracellular signal-regulated kinase; pERK, phosphorylated ERK; FoxO, forkhead box transcription factor O; sir2-1/SIRT1, sirtuin 1; DG, dentate gyrus; HO-1, heme oxygenase-1; cAMP, cyclic adenosine monophosphate; PKA, protein kinase A; GR, glucocorticoid receptor; FKBP5, FK506 binding protein 5; SGK1, serum- and glucocorticoid-inducible kinase 1; NSC, neural stem cell; NPC, neuronal precursor cell; FoxG1, forkhead box G1; TNF-α, tumor necrosis factor alpha; PI3K, phosphoinositide 3-kinases; FGF-2, fibroblast growth factor 2; fMRI, functional magnetic resonance imaging; DCX, doublecortin.